McKesson Draws FDA’s First DSCSA-Related Warning Letter

The FDA issued its first warning letter under the Drug Supply Chain Security Act (DSCSA), hitting McKesson for violating verification requirements and allegedly shipping illegitimate product.
Source: Drug GMP Report